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Abstract
Objective To systematically review the published data on the culture yield of a repeat (second) percutaneous image-guided
biopsy after negative initial biopsy in suspected spondylodiscitis.
Materials and methods A systematic search was performed of the PubMed/Medline and Embase databases. The methodological
quality of the studies included was assessed. The proportions of positive cultures among all initial biopsies and second biopsies
(after a negative initial biopsy) were calculated for each study and assessed for heterogeneity (defined as I2 > 50%).
Results Eight studies, comprising a total of 107 patients who underwent a second percutaneous image-guided biopsy after a
culture-negative initial biopsy in suspected spondylodiscitis, were included. All eight studies were at risk of bias and were
concerning with regard to applicability, particularly patient selection, flow of patients through the study, and timing of the biopsy.
The proportions of positive cultures among all initial biopsies ranged from 10.3 to 52.5%, and were subject to heterogeneity (I2 =
73.7%). The proportions of positive cultures among all second biopsies after negative initial biopsy ranged from 0 to 60.0%, and
were not subject to heterogeneity (I2 = 38.7%).
Conclusion Although a second percutaneous image-guided biopsy may have some value in patients with suspected
spondylodiscitis, its exact value remains unclear, given the available poor-quality evidence. Future well-designed studies are
needed to determine the role of a second percutaneous image-guided biopsy in this setting. Such studies should clearly describe
the spectrum of patients that was selected for a second percutaneous image-guided biopsy, the method of biopsy, and differences
compared with the first biopsy, if any.
Keywords Biopsy . CT . Culture yield . Spine infection . Spondylodiscitis
Introduction
Spondylodiscitis refers to infection of the vertebrae and inter-
vertebral disc [1]. The incidence of spondylodiscitis is approx-
imately 2.4 cases per 100,000 population [2, 3], and is on a
steady rise owing to an aging population with inherent co-mor-
bidities, and improved case ascertainment, particularly related
to the widespread use of magnetic resonance imaging (MRI)
[1]. Because of its nonspecific presentation, a delay of 6–
8 weeks between the onset of symptoms and diagnosis is not
unusual [1, 2]. However, because spondylodiscitis can be com-
plicated by abscess formation, orthopedic complications (verte-
bral collapse and hyperkyphosis), neurological complications
(motor weakness or paralysis), and even death (in approximate-
ly 6%) [1, 2], timely diagnosis and treatment initiation are es-
sential. Current Infectious Diseases Society of America (IDSA)
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guidelines recommend performing spine MRI and obtaining
blood cultures in all patients with suspected spondylodiscitis
[4–6]. The same guidelines also recommend an image-guided
biopsy when a microbiological diagnosis has not been
established by blood cultures or serological tests [4, 5]. A recent
meta-analysis showed the culture yield of the initial image-
guided biopsy in spondylodiscitis to be approximately 48%
[7]. However, when both blood and biopsy cultures remain
negative, it is unclear whether empirical antibiotic therapy
should be started, if a repeat (second) image-guided biopsy
should be performed, or if more invasive procedures such as
percutaneous endoscopic discectomy and drainage (PEDD) or
open excisional biopsy should be considered [7]. The advan-
tage of a second image-guided biopsy is that it is less invasive
than PEDD or an open excisional biopsy. However, because of
the limited number of studies on this topic with relatively small
sample sizes and heterogeneous methodology, the culture yield
of a second image-guided biopsy is still unclear. Theoretically,
if the patient spectrum and technical factors related to the
biopsy are the same for the first and second attempts, the
culture yields will be the same. However, this may not be the
case in clinical practice. Information on the culture yield of
a second image-guided biopsy, as performed in clinical
practice, is crucial for evidence-based clinical decision-
making. Therefore, the aim of this study was to systemati-
cally review published data on the culture yield of a second
percutaneous image-guided biopsy after a negative initial
biopsy in patients with suspected spondylodiscitis.
Materials and methods
Search strategy
The PubMed/Medline and Embase databases were systemati-
cally searched for articles on the culture yield of a second per-
cutaneous image-guided biopsy after a negative initial biopsy in
suspected spondylodiscitis. The search comprised a combina-
tion of the search terms Bspondylodiscitis OR spondylodiskitis
OR discitis OR diskitis OR spondylitis OR spinal osteomyelitis
OR vertebral osteomyelitis^ AND Bbiopsy OR biopsies OR
aspiration OR aspirations OR sample OR samples OR sam-
pling OR samplings^ AND Bcomputed tomography OR com-
puterized tomography OR CT OR CT-guided OR fluoroscopic
OR percutaneous.^ No date restriction was applied. The search
was updated to 18 November 2017. References of articles that
remained after the selection process were screened for poten-
tially suitable additional articles.
Study selection
Studies investigating the culture yield of a second percutane-
ous image-guided biopsy after a negative initial biopsy in
suspected spondylodiscitis were eligible for inclusion. No lan-
guage restriction was applied. Conference abstracts, case re-
ports or series, editorials or letters, review articles, and meta-
analyses were excluded. Articles that only reported the culture
yield of the initial percutaneous, image-guided biopsy and that
not did report or allow for the extraction of the culture yield of
the second biopsy after a negative initial biopsy, were exclud-
ed. Articles that only included patients who underwent aspi-
ration of postoperative paraspinal fluid collections or PEDD
were excluded. When the same patient data were presented in
more than one article, the article with the largest number of
patients was selected. Three researchers (Ö.K, H.J.A.A., and
T.C.K.) reviewed the titles and abstracts of the retrieved arti-
cles in consensus, applying the previously mentioned inclu-
sion and exclusion criteria. Clearly ineligible articles were
excluded at this stage. Subsequently, the same three re-
searchers jointly reviewed the full text version of the remain-
ing articles to determine their eligibility for inclusion.
Study quality
Methodological quality of the studies included was assessed
using the Quality Assessment of Studies of Diagnostic
Accuracy Included in Systematic Reviews (QUADAS)-2 tool
[8]. The QUADAS-2 tool comprises four domains: patient
selection, index test, reference standard, and flow and timing
[8]. Each domain is assessed in terms of risk of bias, and the
first three domains are also assessed in terms of concerns
regarding applicability [8]. In the present study, image-
guided biopsy and microbiological culture can be considered
as both index test and reference test. Therefore, index test and
reference standard were combined into one domain called
Bbiopsy^ for both risk of bias and applicability assessment.
Risk of bias and concerns about applicability for each domain
were judged to be Bhigh,^ Bunclear,^ or Blow.^ If a study is
judged as Blow^ on all domains relating to bias or applicabil-
ity, then it is appropriate to have an overall judgment of Blow
risk of bias^ or Blow concern regarding applicability^ for that
study [8]. If a study is judged to be Bhigh^ or Bunclear^ in one
or more domains, then it may be judged to be Bat risk of bias^
or as having Bconcerns regarding applicability^ [8].
Statistical analysis
The proportions of positive cultures (i.e., cultures with isolat-
ed bacteria in the biopsy) among all initial biopsies and second
biopsies (after a negative initial biopsy) were calculated for
each individual study. Heterogeneity in positive culture yields
across individual studies was assessed using the I2 statistic,
with heterogeneity defined as I2 > 50% [9]. Statistical analyses
were performed using Comprehensive Meta-Analysis Version
3 software (Biostat, Englewood, IL, USA).
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Results
Literature search
The systematic search yielded 1,300 articles from
PubMed/Medline and 920 articles from Embase. After
reviewing titles and abstracts, 78 PubMed/Medline
indexed articles and 62 Embase indexed articles
remained. After discarding duplicates, 93 potentially el-
igible articles remained, and these were retrieved in full-
text format. After reviewing the full-text article, 85 ar-
ticles were excluded because they only reported the cul-
ture yield of the initial percutaneous image-guided biop-
sy and did not report or allow for the extraction of the
culture yield of the repeat biopsy after a negative initial
biopsy. Finally, eight studies remained [10–17], com-
prising a total of 107 patients who underwent a second
percutaneous image-guided biopsy after a negative ini-
tial biopsy in suspected spondylodiscitis. The character-
istics of these studies are displayed in Tables 1 and 2.
Methodological quality assessment
Results of the quality assessment using the QUADAS-2 tool
are displayed in Table 3. Overall, all studies were at risk of
bias and all studies had concerns regarding applicability.
There was a high risk of bias in the domain patient selection
in 7 studies [10–16], because only a minority of patients
with negative initial biopsy cultures underwent a second
biopsy and it was unclear why these patients were selected
for repeat biopsy. There was an unclear risk of bias and
applicability concern in the domain of biopsy in 7 studies,
because they did not describe sufficient details on how per-
cutaneous image-guided biopsy was performed in terms of
image guidance, needle size, and number of biopsy samples
acquired [10–12, 14–17]. There was unclear risk of bias in
the domain of flow and timing in all 8 studies [10–17],
because of the time frame between MRI, the first biopsies
and second biopsies were not described. In addition, in 7
studies it was unclear if patients received antibiotic treat-
ment between the first and second biopsies [10–15, 17].
There was an unclear applicability concern in the domain
of patient selection in all 8 studies [10–17], because it was
unc l e a r i f pa t i en t s w i t h a p r ev iou s h i s t o ry o f
spondylodiscitis were included, which patients were select-
ed for second biopsy, and which of these patients had al-
ready been treated with antibiotics. In addition, in 4 studies
it was unclear if MRI had been performed at all [12, 13, 15,
17], in 4 other studies no (clear) MRI criteria for
spondylodiscitis were reported [10, 11, 14, 16], and in 2
Table 3 Quality assessment of the studies included using the QUADAS-2 tool [8]
Study Risk of bias Applicability concerns
Patient selection Biopsy Flow and timing Patient selection Biopsy
Ahuja and Sharma [10] High Low Unclear Unclear Low
Terreaux et al. [11] High Low Unclear Unclear Low
Gras et al. [12] High Low Unclear Unclear Low
Kim et al. [13] High Low Unclear Unclear Low
Gasbarrini et al. [14] High Low Unclear Unclear Low
Lora-Tamayo et al. [15] High Low Unclear Unclear Low
De Lucas et al. [16] High Low Unclear Unclear Low
Friedman et al. [17] Low Unclear Unclear Unclear Unclear
The following signaling questions were used to assess the risk of bias and applicability concerns (which were then scored as high risk, low risk, or
unclear):
Risk of bias:
1. Patient selection. Didmost patients with negative initial biopsy cultures undergo a repeat biopsy?Was it reported why patients were selected for repeat
biopsy?
2. Biopsy. Could the conduct or interpretation of biopsy have introduced bias?
3. Flow and timing.WasMRI performed within 2 months before tissue biopsy?Was the repeat biopsy performed within 1 month of the initial biopsy and
was no therapy administered between the initial and repeat biopsies?
Applicability concerns:
4. Patient selection. Were patients with a previous history of spondylodiscitis excluded? Were patients with positive blood cultures before biopsy
excluded? Was MRI performed before biopsy and were the criteria for positivity reported? Which patients underwent a repeat biopsy after a negative
initial biopsy?
5. Biopsy. Was fluoroscopic or CT guidance used? What needle size was used? How many biopsy samples were acquired?
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Table 4 Results of included studies












Ahuja and Sharma [10] 19/45 (42.2%) Escherichia coli (n = 2)
Propronibacterium acnes (n = 2)
Staphylococcus aureus (n = 2)
Candida albicans (n = 1)
Coagulase-negative staphylococci (n = 1)
Enterococcus faecium (n = 1)
Group B hemolytic streptococci (n = 1)
Klebsiella oxytoca (n = 1)
Methicillin-resistant Staphylococcus aureus
(n = 1)
Mycobacterium tuberculosis = (n = 1)
Pseudomonas aeruginosa = (n = 1)
Staphylococcus capitis = (n = 1)
Streptococcus sanguinis = (n = 1)
Staphylococcus aureus and
Propionibacterium acnes (n = 1)
Coagulase-negative staphylococci,
Propionibacterium acnes, and
Streptococcus mutans (n = 1)
Nonhemolytic streptococci and
Propionibacterium spp. (n = 1)
1/7 (14.3%) Staphylococcus epidermidis
and Propionibacterium
acnes (n = 1)
Terreaux et al. [11] 33/63 (52.4%) Methicillin-susceptible Staphylococcus
aureus (n = 9)
Staphylococcus epidermidis (n = 8)
Mycobacterium tuberculosis (n = 3)
Streptococcus constellatus (n = 3)
Propionibacterium acnes = (n = 2)
Methicillin-resistant Staphylococcus aureus
(n = 1)
Enterococcus hirae (n = 1)
Klebsiella pneumoniae (n = 1)
Staphylococcus caprae (n = 1)
Streptococcus mutans (n = 1)
Streptococcus dysgalactiae (n = 1)
Streptococcus milleri type 2 (n = 1)
Escherichia coli (n = 1)
6/10 (60.0%) Streptococcus (n = 3)





Gras et al. [12] 59/136 (43.4%) NR 13/33 (39.4%) NR
Kim et al. [13] 51/170 (30.0%) Mycobacterium tuberculosis (n = 26)
Staphylococcus aureus (n = 13)
Streptococcus agalactiae (n = 4)
Streptococcus viridans (n = 2)
Coagulase-negative Staphylococcus
organisms (n = 1)
Escherichia coli (n = 1)
Enterococcus faecalis (n = 1)
Enterobacter cloacae (n = 1)
Staphylococcus epididymis (n = 1)
Klebsiella (n = 1)
2/26 (7.7%) Mycobacterium tuberculosis
(n = 1)
Staphylococcus aureus (n = 1)
Gasbarrini et al. [14] 11/24 (45.8%)a Mycobacterium tuberculosis (n = 3)




aureus (n = 1)
Streptococcus spp. (n = 1)
Streptococcus constellatus (n = 1)
Pseudomonas aeruginosa (n = 1)
Escherichia coli (n = 1)
0/2 (0.0%) NA
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studies it was unclear whether patients with positive blood
cultures before biopsy were excluded [10, 16].
Culture yield of the repeat biopsy
Culture yields of initial and second biopsies for each individual
study are displayed in Table 4. The proportions of positive
cultures among all initial biopsies (n = 507) ranged from 10.3
to 52.5% (with I2 = 73.7%). The proportions of positive cul-
tures among all second biopsies (n = 107) ranged from 0 to
60.0% (with I2 = 38.7%; Fig. 1).
Discussion
Table 4 (continued)












Lora-Tamayo et al. [15] 3/29 (10.3%) NR 2/6 (33.3%) NR
De Lucas et al. [16] NRb NR 1/4 (25.0%)d Mycobacterium
tuberculosis (n = 1)
Friedman et al. [17] 21/40 (52.5%) NR 8/19 (42.1%) NR
NR not reported, NA not applicable
a Including one case that was culture-negative, but in whom Mycobacterium tuberculosis was molecularly detected by polymerase chain reaction
b Initial and second CT-guided biopsy results could not be separated with certainty
c No diagnoses other than spondylodiscitis (if present) were reported after initial or second biopsy









Positive cultures Negative cultures
Fig. 1 Number of positive and
negative cultures on the repeat
biopsy (after a negative initial
biopsy) in suspected
spondylodiscitis, for each of the
eight studies included
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This systematic review included 8 studies, comprising a total
sample size of 107 patients who underwent a second
image-guided biopsy after a culture-negative initial biopsy in
suspected spondylodiscitis. The positive culture yield of a
second CT-guided biopsy ranged between approximately 10
and 50% of the studies included. However, these percentages
should be interpreted cautiously because the overall quality of
the studies included was poor to moderate, with several im-
portant methodological concerns. First, in 7 studies, only a
minority of patients with a negative initial biopsy cultures
underwent a second biopsy [10–16]. As 6 of these 7 studies
were performed retrospectively [10–13, 15, 16], the decision
to rebiopsy was most likely based on clinical and radiological
grounds, which may include insufficient treatment response
and disease extent on MRI (e.g., the presence of large
paravertebral phlegmon and/or abscess). These factors might
overestimate the culture yield if extrapolated to all patients
with a negative initial biopsy culture. Although the culture-
positive rebiopsy yields do reflect clinical practice, the exact
reasons why the patients in these studies were rebiopsied,
remain unclear. Furthermore, from the 8 studies included, it
was unclear how many of the patients with culture-negative
initial biopsies eventually had positive blood cultures, how
many underwent PEDD or open biopsy, and how many re-
ceived empirical antibiotic therapy without any further diag-
nostic interventions [10–17]. Second, there was poor reporting
on the use and interpretation of MRI before biopsy. MRI is
regarded as the imaging method of choice for the detection of
spondylodiscitis and the discrimination from other conditions
such as non-infectious inflammatory and degenerative disease
that may simulate spinal infection [18]. For these reasons,
IDSA guidelines recommend performing spine MRI before
biopsy in all patients with suspected spondylodiscitis [4–6].
However, 4 studies did not report if MRI was performed [12,
13, 15, 17] and the 4 other studies did not report (clear) MRI
criteria for spondylodiscitis [10, 11, 14, 16]. In addition, none
of the eight studies included reported the time interval be-
tween MRI and biopsy. This rather poor prebiopsy MRI as-
sessment may have negatively affected the culture yields be-
cause of potential data contamination with spondylodiscitis
mimickers such as Modic type 1 degeneration, acute
Schmorl node, and (osteoporotic) fractures [18]. Third, none
of the 8 studies reported if patients with a previous history of
spondylodiscitis had been excluded. MRI findings in these
patients are nonspecific, correlate poorly with clinical and
laboratory findings, and may overestimate the diagnosis of
spondylodiscitis [19]. This issue may have affected culture
yields. Fourth, seven of the eight studies included reported
variable anatomical targets for biopsy (disc, vertebral corpus,
and/or paravertebral soft tissue) [11–17], whereas one study
did not report which anatomical target was biopsied [10].
Variation in anatomical targets may also have affected culture
yields. On the other hand, a previous study has shown that
there were no statistically significant differences between the
yields of endplate-disc, disc-only, and paravertebral soft-tissue
biopsies [20]. Despite the variations in patient populations and
methodology among the studies included, proportions of pos-
itive culture yields among second biopsies were statistically
homogeneous, but this may be due to the relatively small
sample sizes of the studies included.
This systematic review had several limitations. First,
although 93 potentially eligible articles were considered
after screening titles and abstracts, only 8 studies with
107 patients who underwent repeat biopsy, remained for
analysis. Second, owing to the low number of studies
and underreported data, it was not possible to perform
further subgroup analyses to determine if any clinical,
laboratory, and/or imaging parameters are associated
with positive repeat biopsy cultures. Third, although
the culture yield of second biopsy was determined, it
remains unclear which strategy (i.e., additional blood
culture, second biopsy, PEDD, open biopsy, and/or em-
pirical antibiotic therapy without any further diagnostic
interventions) is most (cost-)effective in patients with a
culture-negative initial biopsy. Thus, future prospective
studies with larger sample sizes are needed.
In conclusion, although a second percutaneous image-
guided biopsy may have some value in patients with
suspected spondylodiscitis, its exact value remains un-
clear given the poor-quality evidence available. Future
well-designed studies are needed to determine the role
of a second percutaneous image-guided biopsy in this
setting. Such studies should clearly describe the spec-
trum of patients that was selected for a second percuta-
neous image-guided biopsy, the method of biopsy, and
differences compared with the first biopsy, if any.
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